Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Marchesi

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Journal of Hematology & Oncology|May 18, 2021
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institutionFulvia Pimpinelli, Francesco Marchesi, Giulia Piaggio, et al.
Clinical and Translational Science|July 29, 2023
Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life studyPierantonio Menna, Francesco Marchesi, Chiara Cattaneo, et al.
Frontiers in Cellular and Infection Microbiology|December 28, 2020
Biofilm Production by Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Significantly Increases the Risk of Death in Oncological PatientsEnea Gino Di Domenico, Ilaria Cavallo, Francesca Sivori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2018
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestionsAndrea Tendas, Francesco Marchesi, Andrea Mengarelli, et al.
Expert Review of Hematology|December 30, 2017
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disordersAlessandro Busca, Simone Cesaro, Luciana Teofili, et al.
Frontiers in Oncology|December 19, 2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experienceFrancesco Autore, Luca Stirparo, Idanna Innocenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2022
Glycan degradation promotes macroautophagyAlice D Baudot, Victoria M-Y Wang, Josh D Leach, et al.
Journal of Clinical Medicine|April 12, 2022
In <i>BCR-ABL1</i> Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces HypofibrinogenemiaElisa Buzzatti, Fabio Forghieri, Giovangiacinto Paterno, et al.
Nature|August 31, 2007
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage responseChiara Gorrini, Massimo Squatrito, Chiara Luise, et al.
Medical Mycology|October 10, 2017
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?Corrado Girmenia, Luciana Annino, Alice Bertaina, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Journal of Hematology & Oncology|May 18, 2021
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institutionFulvia Pimpinelli, Francesco Marchesi, Giulia Piaggio, et al.
Clinical and Translational Science|July 29, 2023
Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life studyPierantonio Menna, Francesco Marchesi, Chiara Cattaneo, et al.
Frontiers in Cellular and Infection Microbiology|December 28, 2020
Biofilm Production by Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Significantly Increases the Risk of Death in Oncological PatientsEnea Gino Di Domenico, Ilaria Cavallo, Francesca Sivori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2018
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestionsAndrea Tendas, Francesco Marchesi, Andrea Mengarelli, et al.
Expert Review of Hematology|December 30, 2017
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disordersAlessandro Busca, Simone Cesaro, Luciana Teofili, et al.
Frontiers in Oncology|December 19, 2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experienceFrancesco Autore, Luca Stirparo, Idanna Innocenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2022
Glycan degradation promotes macroautophagyAlice D Baudot, Victoria M-Y Wang, Josh D Leach, et al.
Journal of Clinical Medicine|April 12, 2022
In <i>BCR-ABL1</i> Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces HypofibrinogenemiaElisa Buzzatti, Fabio Forghieri, Giovangiacinto Paterno, et al.
Nature|August 31, 2007
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage responseChiara Gorrini, Massimo Squatrito, Chiara Luise, et al.
Medical Mycology|October 10, 2017
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?Corrado Girmenia, Luciana Annino, Alice Bertaina, et al.
Pageof 15